Dec 17, 2019 - Novartis' (NVS) asthma candidate, fevipiprant, fails to meet endpoint in the phase III LUSTER studies.
Dec 24, 2019 - Allergan (AGN) gets FDA nod for Ubrelvy for the acute treatment of migraine with or without aura in adults.
Dec 27, 2019 - Patients who inherit life-threatening blood disorders have some important new treatment options.
Dec 28, 2019 - Few biotech companies ever reach that valuation, and if they do, you should snap them up for your portfolio.
Dec 31, 2019 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Jan 09, 2020 - Top Analyst Reports for Novartis, McDonald's & Bristol-Myers Squibb
Jan 10, 2020 - The Zacks Analyst Blog Highlights: Novartis, McDonald's, Bristol-Myers Squibb, CME and UBS
Jan 13, 2020 - Cholesterol-lowering inclisiran could be available in the country as early as 2021.
Jan 14, 2020 - The results should help the upstart drug to compete with Cosentyx.
Jan 15, 2020 - New treatments for breast cancer, multiple sclerosis, and others make the drugmaker's stock a more compelling buy in 2020.